IBC Life Sciences

The leading provider of scientific, technological and business information

Main menu

My IBC

Login form

Sign Up

Home»Events»TIDES: Oligonucleotide...Event Overview»Venue and Travel Information

TIDES: Oligonucleotide and Peptide® Technology and Product Development

CSS

CSS - agenda

Event Information

April 25 - 28, 2010 · Hynes Convention Center and Sheraton Boston Hotel · Boston, MA

Now the most comprehensive industry event with the addition of the 2nd Annual Oligonucleotide Therapeutics Discovery conference at the same venue

Alt language

Alternate Language Options: Japanese Korean Taiwanese Chinese

Document Title

Venue and Travel Information

Venue and Travel Information

Venue Information:

John B Hynes Veterans Memorial Convention Center
900 Boylston Street
Boston, MA 02116
United States
+(1) 617-954-2000
web: http://www.mccahome.com

Hotel:

Book Today:
IBC's Discounted Rate Expires March 29th

Sheraton Boston Hotel
39 Dalton Street
Boston, MA 02199
Phone: (617) 236-2000

Please call the Starwood reservations number 1-888-627-7054 or access the housing website before March 29, 2010 to be included in IBC's dedicated room block. Please identify yourself as part of IBC's TIDES® Conference to receive the reduced room rate. Be sure to make your reservations as soon as possible as rooms tend to fill up very quickly and all reservations are subject to availability.

Hotel Reservation Policies:

  1. A first and last night non-refundable deposit is required at the time of reservation.
  2. Cancellations and changes to a reservation will be accepted without further financial responsibility up until 72 hours prior to your arrival date. Your credit card is subject to being charged for your full reservation if cancellation or changes to a reservation are received any less then 72 hours of your arrival date.
course banner

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com

Powered by Interactive Agency Janmedia Interactive, Inc.